These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 26775015)
1. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes. Is there any doubt? Martínez-Brocca MA Endocrinol Nutr; 2016 Mar; 63(3):103-5. PubMed ID: 26775015 [No Abstract] [Full Text] [Related]
2. [Influence of the treatment with continuous subcutaneous insulin infusion (CSII) in the improvement of the quality of life of patients with type 1 diabetes mellitus]. Casas-Oñate ML; Montoya-Martínez D Enferm Clin; 2010; 20(4):216-21. PubMed ID: 20561806 [TBL] [Abstract][Full Text] [Related]
5. Identifying patients for insulin pump therapy. Morrison G; Weston P Nurs Times; 2013 Mar 12-18; 109(10):14, 16, 18. PubMed ID: 23560341 [TBL] [Abstract][Full Text] [Related]
6. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Siebenhofer A; Jeitler K; Berghold A; Horvath K; Pieber TR Diabet Med; 2009 Mar; 26(3):311-2; author reply 312-3. PubMed ID: 19317829 [No Abstract] [Full Text] [Related]
7. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. Jarosz-Chobot P Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073 [TBL] [Abstract][Full Text] [Related]
9. Challenges in Delivering Smaller Doses of Insulin. Frohnert BI; Alonso GT Diabetes Technol Ther; 2015 Sep; 17(9):597-9. PubMed ID: 26317878 [No Abstract] [Full Text] [Related]
10. Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation. Reali MF; Festini F; Neri AS; Taccetti G; Repetto T; Chiarelli F; Toni S J Cyst Fibros; 2006 Jan; 5(1):67-8. PubMed ID: 16233992 [No Abstract] [Full Text] [Related]
11. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes. Weintrob N; Shalitin S; Phillip M Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365 [TBL] [Abstract][Full Text] [Related]
12. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Liebl A; Hoogma R; Renard E; Geelhoed-Duijvestijn PH; Klein E; Diglas J; Kessler L; Melki V; Diem P; Brun JM; Schaepelynck-Bélicar P; Frei T; Diabetes Obes Metab; 2009 Nov; 11(11):1001-8. PubMed ID: 19740082 [TBL] [Abstract][Full Text] [Related]
13. The benefits of insulin pump therapy in children and adolescents with type 1 diabetes. Woerner S J Pediatr Nurs; 2014; 29(6):712-3. PubMed ID: 25176031 [No Abstract] [Full Text] [Related]
18. Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues? Currie CJ Diabet Med; 2007 Oct; 24(10):1058-9. PubMed ID: 17888127 [No Abstract] [Full Text] [Related]
19. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615 [No Abstract] [Full Text] [Related]
20. Access to insulin pump therapy and continuous glucose monitoring - is it an even playing field? Hitman GA Diabet Med; 2012 Aug; 29(8):971. PubMed ID: 22803777 [No Abstract] [Full Text] [Related] [Next] [New Search]